Itani Kamal M F, Jensen Erin H, Finn Tyler S, Tomassini Joanne E, Abramson Murray A
Department of Surgery, Veterans Affairs Boston Health Care System, West Roxbury, MA 02132, USA.
Surg Infect (Larchmt). 2008 Apr;9(2):131-7. doi: 10.1089/sur.2007.034.
The effectiveness of prophylactic antibiotics in the prevention of surgical site infection (SSI) after elective colorectal surgery is dependent on many factors, including the body mass index (BMI) of the patient. In this study, the association of BMI and type of antibiotic prophylaxis with SSI was evaluated in patients undergoing elective colorectal surgery.
A post-hoc analysis was performed using data obtained from a multicenter randomized, double-blind study of 1,002 patients undergoing elective colorectal surgery who received prophylactic administration of ertapenem (1 g) or cefotetan (2 g). Among 650 evaluable patients, the effect of BMI and type of antibiotic prophylaxis on SSI rates was assessed four weeks after surgery. Mechanical bowel preparation was standardized, and no patient received oral antibiotics; intravenous antibiotics were not repeated during or after surgery.
The majority of patients had a BMI between 18.5 and 39.9 kg/m2. Regardless of the type of prophylaxis, SSI rates were significantly higher in patients with a BMI > or = 30 kg/m2 than in those with a BMI < 30 kg/m2. However, failure, defined as SSI, was significantly less common after ertapenem than after cefotetan prophylaxis at both BMI < 30 kg/m2 (12.7% vs. 26.4%, respectively; difference -13.7; 95% confidence interval [CI] -21.0, -6.5) and BMI > or = 30 kg/m2 (26.7% vs. 41.9%, respectively; difference -15.3; 95% CI -28.2, -2.0). The most prevalent type of SSI was superficial incisional infection, which was more common with both treatments in patients with a BMI > or = 30 kg/m2; however, the incidence of superficial SSI was lower after ertapenem than cefotetan prophylaxis.
In patients undergoing elective colorectal surgery, the incidence of SSI, specifically superficial incisional SSI, was higher in patients with a BMI > or = 30 kg/m2, regardless of the prophylactic antibiotic given. Ertapenem prophylaxis was more effective than cefotetan in the prevention of SSI at any BMI.
预防性抗生素在择期结直肠手术后预防手术部位感染(SSI)的有效性取决于多种因素,包括患者的体重指数(BMI)。在本研究中,对接受择期结直肠手术的患者评估了BMI及预防性抗生素类型与SSI之间的关联。
使用从一项多中心随机、双盲研究中获得的数据进行事后分析,该研究纳入了1002例接受择期结直肠手术并接受厄他培南(1g)或头孢替坦(2g)预防性给药的患者。在650例可评估患者中,术后四周评估BMI和预防性抗生素类型对SSI发生率的影响。肠道机械准备标准化,无患者接受口服抗生素;手术期间及术后未重复静脉使用抗生素。
大多数患者的BMI在18.5至39.9kg/m²之间。无论预防性用药类型如何,BMI≥30kg/m²的患者SSI发生率显著高于BMI<30kg/m²的患者。然而,在BMI<30kg/m²(分别为12.7%和26.4%;差异-13.7;95%置信区间[CI]-21.0,-6.5)和BMI≥30kg/m²(分别为26.7%和41.9%;差异-15.3;95%CI-28.2,-2.0)时,定义为SSI的失败情况在厄他培南预防后比头孢替坦预防后显著更少见。最常见的SSI类型是浅表切口感染,在BMI≥30kg/m²的患者中,两种治疗方式下这种感染都更常见;然而,厄他培南预防后的浅表SSI发生率低于头孢替坦预防。
在接受择期结直肠手术的患者中,无论给予何种预防性抗生素,BMI≥30kg/m²的患者SSI发生率,尤其是浅表切口SSI发生率更高。在任何BMI水平下,厄他培南预防在预防SSI方面比头孢替坦更有效。